Acupuncture for Chemical Therapy Induced Nausea and Vomiting
NCT ID: NCT02842307
Last Updated: 2016-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2010-01-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting
NCT02369107
Acupuncture for Chemotherapy-Induced Nausea and Vomiting
NCT02195921
The Different Effectiveness of Single Acupoint(PC6 or CV12) vs Matching Acupoints(PC6 and CV12) in Chemotherapy-induced Nausea and Vomiting
NCT02195908
The Comparative Study on the Efficacy and Safety of Single Acupoint and Matching Acupoints
NCT03061396
Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting
NCT00360841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A(senior acupuncturists)
Manual acupuncture implemented by senior acupuncturists (clinical experience \>15 years)
Manual acupuncture implemented by senior acupuncturists
Manual acupuncture once per day. No limitation on points, manipulations and time per session. Senior acupuncturists have to have more than 15 years of acupuncture clinical practice experience.
B(junior acupuncturists)
Manual acupuncture implemented by junior acupuncturists (clinical experience \<5 years)
Manual acupuncture implemented by junior acupuncturists
Manual acupuncture once per day. No limitation on points, manipulations and time per session. Junior acupuncturists have to have less than 5 years of acupuncture clinical practice experience.
C(P6 points)
Manual acupuncture on P6 points by junior acupuncturists (clinical experience \<5 years)
Manual acupuncture on P6 point
Manual acupuncture implemented by junior acupuncturists once per day. P6 point, bilaterally, should achieve deqi sensation by even manipulations. Junior acupuncturists have to have less than 5 years of acupuncture clinical practice experience.
D(no acupuncture)
No acupuncture treatment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Manual acupuncture implemented by senior acupuncturists
Manual acupuncture once per day. No limitation on points, manipulations and time per session. Senior acupuncturists have to have more than 15 years of acupuncture clinical practice experience.
Manual acupuncture implemented by junior acupuncturists
Manual acupuncture once per day. No limitation on points, manipulations and time per session. Junior acupuncturists have to have less than 5 years of acupuncture clinical practice experience.
Manual acupuncture on P6 point
Manual acupuncture implemented by junior acupuncturists once per day. P6 point, bilaterally, should achieve deqi sensation by even manipulations. Junior acupuncturists have to have less than 5 years of acupuncture clinical practice experience.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must receive cancer chemotherapy containing cisplatin
* Use 5-TH receptor antagonists as an antiemetic drug in the chemotherapy duration
Exclusion Criteria
* Received acupuncture treatments for other conditions less than 4 weeks before chemotherapy treatment
* Severe infection
* Severe heart, liver, kidney and brain diseases
* Cardiac pacemaker
* Radiotherapy or hormone therapy during chemotherapy treatments
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dongzhimen Hospital, Beijing
OTHER
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
OTHER
Xiyuan Hospital of China Academy of Chinese Medical Sciences
OTHER
Beijing University of Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yutong Fei
Associate research fellow
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dongzhimen Hospital, Beijing University of Chinese medicine
Beijing, Beijing Municipality, China
Guanganmen Hospital,China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30901929
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
EBM@BUCM-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.